
浏览全部资源
扫码关注微信
400038 重庆,陆军军医大学(第三军医大学)第一附属医院妇产科
[徐燕,E-mail:xuyancq85@163.comXU Yan, E-mail: xuyancq85@163.com
收稿:2021-06-04,
修回:2021-11-11,
纸质出版:2022-02-15
移动端阅览
张晓林, 任玉香, 冯顺, 等. 459例宫颈高级别鳞状上皮内病变患者HPV感染特点及高危HPV阴性的筛查特征分析[J]. 陆军军医大学学报, 2022,44(3):253-258.
Xiaolin ZHANG, Yuxiang REN, Shun FENG, et al. Features of HPV infection and screening characteristics of high-risk HPV negative in patients with cervical high-grade squamous intraepithelial lesion: a retrospective analysis of 459 cases[J]. Journal of Army Medical University, 2022, 44(3): 253-258.
张晓林, 任玉香, 冯顺, 等. 459例宫颈高级别鳞状上皮内病变患者HPV感染特点及高危HPV阴性的筛查特征分析[J]. 陆军军医大学学报, 2022,44(3):253-258. DOI: 10.16016/j.2097-0927.202106037.
Xiaolin ZHANG, Yuxiang REN, Shun FENG, et al. Features of HPV infection and screening characteristics of high-risk HPV negative in patients with cervical high-grade squamous intraepithelial lesion: a retrospective analysis of 459 cases[J]. Journal of Army Medical University, 2022, 44(3): 253-258. DOI: 10.16016/j.2097-0927.202106037.
目的
2
探讨高危人乳头瘤病毒(high-risk human papillomavirus,HR-HPV)感染特点及其中HR-HPV阴性的筛查特征。
方法
2
对我院妇科门诊2019年1月至2020年8月病理诊断为宫颈高级别鳞状上皮内病变(high grade squamous intraepithelial lesion,HSIL)患者的筛查结果进行回顾性分析,比较HR-HPV、液基薄层细胞学检查(thinprep cytologic test,TCT)以及二者联合筛查异常的阳性检出率。分析避免HR-HPV阴性的HSIL患者漏诊要点。
结果
2
459例HSIL患者中HR-HPV阳性率91.94%;单一感染占71.90%,多重感染占22.22%;单一感染中阳性率最高的是16型(45.76%)。3种方法初筛分流的阳性率分别为77.34%、64.27%和82.79%,三者比较差异有统计学意义(
P
<
0.01)。HR-HPV阴性组中TCT高于不能明确意义的非典型鳞状细胞(atypical squamous cells of undetermined significance
ASCUS)有25例(67.57%);3例(8.11%)TCT为ASCUS及9例(24.32%)TCT低于ASCUS的均因临床症状转诊阴道镜;6例阴道镜初诊正常的均有TCT异常。
结论
2
HSIL患者中HPV感染以HR-HPV感染及单一型感染居多。HR-HPV和TCT联合筛查的阳性率最高。HR-HPV阴性的HSIL患者通常有明显的临床症状和TCT异常。
Objective
2
To investigate the infection features of high-risk human papillomavirus (HR-HPV) and screening characteristics of HR-HPV-negative cases in patients with cervical high-grade squamous intraepithelial lesion (HSIL).
Methods
2
A retrospective analysis was conducted on the screening results of 459 patients who were pathologically diagnosed as cervical HSIL in our hospital from January 2019 to August 2020. The positive detection rates of HR-HPV test
thinprep cytologic test (TCT)
and their joint screening were compared among the patients
and the analysis of key points to avoid missed diagnosis were conducted in HR-HPV negative cases.
Results
2
Among the 459 HSIL patients
the single subtype infection accounted for 71.90% (330 cases)
multiple infection 22.22% (102 cases); the positive rate of HR-HPV was 91.94% (422 cases)
and the monotype infection with the highest positive rate was HPV subtype 16 (45.76%). The positive detection rates of the 3 tests were 77.34%
64.27% and 82.79% respectively
with significant difference (
P
<
0.01). Moreover
25 cases (67.57%) in the HR-HPV negative group had worse than ASCUS results of TCT
while 3 cases (8.11%) with ASCUS and 9 cases (24.32%) with negative TCT results were referred to colposcopy due to clinical symptoms
and 6 HR-HPV negative cases with normal colposcopy showed abnormal TCT results.
Conclusion
2
HR-HPV infection and monotype infection are predominant in cervical HSIL patients. The combined screening of HR-HPV and TCT has the highest positive diagnostic rate
while the HR-HPV negative patients usually have obvious clinical symptoms and TCT abnormalities.
GUTNIK H, KASTELIC P, OŠTRBENK VALENC ČAK A, et al . Histomorphologic assessment and distribution of high-risk human papillomavirus (HPV) types in cervical high-grade squamous intraepithelial lesions with unusual histomorphologic features[J ] . Virchows Arch, 2020, 476(2): 2 51-260. DOI: 10.1007/s00428-019-02694-7.
马艳, 傅佳, 卢朝霞. 高危型HPV阴性宫颈癌前病变的临床特点及预后情况[J]. 江西医药, 2020, 55(5): 615-616, 630. DOI: 10.3969/j.issn.1006-2238.2020.05.043.
MA Y, FU J, LU Z X. The clinical features and prognosis of high-risk HPV-negative cervical precancerous lesions[J]. Jiangxi Med J, 2020, 55(5): 615-616, 630. DOI: 10.3969/j.issn.1006-2238.2020.05.043.
代廷耕, 刘晓霞, 李曼, 等. HPV阴性的宫颈癌及癌前病变的原因分析[J]. 中国试验诊断学, 2016, 20(3): 519-521. DOI: 1007-4287(2016)03-0519-03.
DAI T G, LIU X X, LI M, et al . Cause analysis of HPV negative cervical cancer and precancerous lesions[J ] . Chin J Lab Diagn, 2016, 20(3): 519-521. DOI: 1007-4287(2016)03-0519-03.
何鑫, 陶绘丞, 王淑珍, 等. 高危型人乳头瘤病毒阴性/不典型鳞状细胞和低度鳞状上皮内病变患者的随访观察[J]. 首都医科大学学报, 2015, 36(2): 205-211. DOI: 10.3969/j.issn.1006-7795.2015.02.009.
HE X, TAO H C, WANG S Z, et al . An analysis of high-risk human papillomavirus DNA-negative cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a retrospective study[J ] . J Cap Med Univ, 2015, 36(2): 205-211. DOI: 10.3969/j.issn.1006-7795.2015.02.009.
赵昀, 魏丽惠. CSCCP关于中国宫颈癌筛查及异常管理相关问题专家共识解读[J]. 实用妇产科杂志, 2018, 34(2): 101-104. DOI: 1003-6946(2018)02-0101-04.
ZHAO Y, WEI L H. Interpretation of CSCCP expert consensus on issues related to cervical cancer screening and anomaly management in China[J]. J Pract Obstet Gynecol, 2018, 34(2): 101-104. DOI: 1003-6946(2018)02-0101-04.
KUKIMOTO I. Human papillomavirus carcinogenesis mediated by APOBEC mutagenesis[J]. Yakugaku Zasshi, 2019, 139(1): 75-79. DOI: 10.1248/yakushi.18-00164-3.
余艳琴, 富诗岚, 徐慧芳, 等. 中国大陆女性体检人群中人乳头瘤病毒型别感染率及九价疫苗中HPV各型别分布的系统评价[J]. 肿瘤预防与治疗, 2019, 32(2): 103-113. DOI: 10.3969/j.issn.1674-0904.2019.02.002.
YU Y Q, FU S L, XU H F, et al . Genotype-specific prevalence and distribution of cervical human papillomavirus in women undergoing health check-ups in mainland China: a systematic review based on population-based studies[J ] . J Cancer Control Treat, 2019, 32(2): 103-113. DOI: 10.3969/j.issn.1674-0904.2019.02.002.issn.1674-0904.2019.02.002.
HE L, HE J. Distribution of high-risk HPV types among women in Sichuan Province, China: a cross-sectional study[J]. BMC Infect Dis, 2019, 19(1): 390. DOI: 10.1186/s12879-019-4038-8.
李乐, 王瑞. 14962例体检女性HPV感染特征及联合TCT筛查宫颈病变的价值[J]. 第三军医大学学报, 2020, 42(15): 1548-1554. DOI: 10.16016/j.1000-5404.202004176.
LI L, WANG R. Characteristics of HPV infection and value of its combination with TCT in screening cervical lesions: report based on 14 962 women taking physical examination[J]. J Third Mil Med Univ, 2020, 42(15): 1548-1554. DOI: 10.16016/j.1000-5404.202004176.
余娟平, 魏琦, 王倩倩, 等. 安徽地区17160例健康体检女性人乳头瘤病毒感染状况及基因分型[J]. 中华试验和临床感染病杂志(电子版), 2019, 13(5): 389-395. DOI: 10.3877/cma.j.issn.1674-1358.2019.05.008.
YU J P, WEI Q, WANG Q Q, et al . Genotypes distribution of human papillomavirus in infected cervical tissue from 17160 women for physical examination in Anhui area[J ] . Chin J Exp Clin Infect Dis Electr Vers, 2019, 13(5): 389-395. DOI: 10.3877/cma.j.issn.1674-1358.2019.05.008.
张师前, 石比伯. 高危型HPV检测在子宫颈病变筛查中的价值[J]. 实用妇产科杂志, 2020, 36(10): 726-729. DOI: 1003-6946(2020)10-0726-04.DOI: 1003-6946(2020)10-0726-04.
ZHANG S Q, SHI B B. The value of high-risk HPV detection in screening of cervical lesions[J]. J Pract Obstet Gynecol, 2020, 36(10): 726-729. DOI:1003-6946(2020)10-0726-04.
KIM J, KIM B K, JEON D, et al . Type-specific viral load and physical state of HPV type 16, 18, and 58 as diagnostic biomarkers for high-grade squamous intraepithelial lesions or cervical cancer[J ] . Cancer Res Treat, 2020, 52(2): 396-405. DOI: 10.4143/crt.2019.152.
刘甚佳, 尹利荣, 李洪林. 高危型HPV感染宫颈病变中E6/E7 mRNA的表达水平[J]. 天津医药, 2015, 43(2): 186-188. DOI: 10.11958/j.issn.0253-9896.2015.02.019.
LIU S J, YIN L R, LI H L. E6/E7 mRNA expression level in cervical lesions with high-risk HPV infection[J]. Tianjin Med J, 2015, 43(2): 186-188. DOI: 10.11958/j.issn.0253-9896.2015.02.019.
CHEN W, ZHENG R, BAADE P D, et al . Cancer statistics in China, 2015[J ] . CA Cancer J Clin, 2016, 66(2): 115-132. DOI: 10.3322/caac.21338.
梁月兰, 赵雪, 耿建祥, 等. 宫颈ASC-US、LSIL和HSIL中HPV感染型别分布的研究[J]. 国际检验医学杂志, 2018, 39(1): 59-62. DOI: 10.3969/j.issn.1673-4130.2018.01.016.
LIANG Y L, ZHAO X, GENG J X, et al . Study on HPV infection types distribution in ASC-US, LSIL and HSIL of uterine cervix[J ] . Int J Lab Med, 2018, 39(1): 59-62. DOI:10.3969/j.issn.1673-4130.2018.01.016.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621